Indo MIM Shares Extend Post-IPO Rally to 82% Above Issue Price, Rise 10% Today as Precision Engineering Story Holds

The Quick Take

• Indo MIM's shares have surged 82% above their IPO issue price and rose another 10% in today's session as the market continues to reward the company's strong FY26 financial performance and differentiated positioning in precision metal injection molding technology.
• The company's Metal Injection Molding (MIM) technology — used across automotive, medical devices, aerospace, and consumer electronics — commands premium margins and serves a global customer base, distinguishing Indo MIM from commodity metal component manufacturers.
• With strong FY26 revenue and profitability growth confirmed, the debate has shifted from 'should investors hold' to 'should investors book profits at 82% gains' — a question that depends on growth visibility for FY27 and whether the valuation premium can be justified.

Indo MIM's post-IPO performance has been exceptional by any measure: an 82% gain from issue price in a relatively short post-listing period reflects strong institutional and retail demand for a company occupying a specialized niche in precision engineering. Metal Injection Molding is a manufacturing process that combines the design flexibility of plastic injection molding with the material properties of metals, enabling complex near-net-shape parts at lower cost than traditional machining. The global MIM market is growing at approximately 7–9% annually, driven by miniaturization trends in electronics, stringent tolerances in medical devices, and lightweighting requirements in automotive and aerospace.

FY26 results confirmed the investment thesis: both revenue and profitability grew strongly, validating the company's ability to scale globally while maintaining quality standards demanded by regulated industries like medical devices and aerospace components. Indo MIM's customer relationships with major multinational OEMs provide revenue visibility that smaller, domestically-focused component manufacturers lack. The company's ability to serve export markets — particularly in Europe and North America where MIM adoption is highest — also provides a natural hedge against domestic demand cyclicality.

The profit-booking question is legitimate after an 82% move from IPO price. At current levels, the stock trades at a premium to Indian mid-cap engineering services peers — a premium that is defensible if management can sustain 20%+ revenue growth and maintain EBITDA margins above 20%. Investors considering entry at current levels should focus on the H2 FY27 order book, export revenue momentum, and capital expenditure plans for capacity expansion. Those holding from IPO should assess whether their investment thesis remains intact at the new valuation before deciding whether to trim positions on further strength.

Synthesized from 1 source.